Ovarian cancer is one of the deadliest gynaecological conditions in the developed world, as it is often detected late into progression. Efforts to improve surgical and chemotherapeutic approaches have only made marginal improvements to patient outcomes over the past 30 years, but there remains potential within immunotherapeutic approaches. Understanding the tumor microenvironment, and particularly the […]
Read More